June 25, 2024

Mineral Supplements Market Size to Cross USD 29.66 Bn by 2033

The global mineral supplements market size accounted for US$ 16.53 billion in 2023 and is projected to reach around USD 29.66 billion by 2033, growing at a CAGR of 6.02% from 2024 to 2033.

Mineral Supplements Market Size 2024 to 2033

Key Points

  • Asia-Pacific dominated the market with the largest market share of 40% in 2023.
  • By product, the calcium segment has contributed the largest market share of 42% in 2023.
  • By formulation, the tablet segment led the market with the biggest market share of 36% in 2023.
  • By application, the general health segment has led the major market share of 41% in 2023.
  • By end-use, the adult segment has accounted more than 48% of market share in 2023.
  • By sales channel, the pharmacies & drug stores segment dominated the market in 2023.

Report Summary

The global mineral supplements market report provides a Point-by-Point and In-Depth analysis of global market size, regional and country-level market size, market share, segmentation market growth, competitive landscape, sales analysis, opportunities analysis, strategic market growth analysis, the impact of domestic and global market key players, value chain optimization, trade regulations, recent developments, product launches, area marketplace expanding, and technological innovations.

The study offers a comprehensive analysis on diverse features, including production capacities, demand, product developments, revenue generation, and sales in the mineral supplements market across the globe.

A comprehensive estimate on the mineral supplements market has been provided through an optimistic scenario as well as a conservative scenario, taking into account the sales of mineral supplements during the forecast period. Price point comparison by region with global average price is also considered in the study.

Download Access to a Free Copy of Our Latest Sample Report@ https://www.precedenceresearch.com/sample/3885

Mineral Supplements Market Scope

Report Coverage Details
Growth Rate from 2024 to 2033 CAGR of 6.02%
Global Market Size in 2023 USD 16.53 Billion
Global Market Size by 2033 USD 29.66 Billion
Largest Market Asia Pacific
Base Year 2023
Forecast Period 2024 to 2033
Segments Covered By Product, By Formulation, By Application, By End-Use, and By Sales Channel
Regions Covered North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa

Key Highlights:

Reports Coverage: It incorporates key market sections, key makers secured, the extent of items offered in the years considered, worldwide containerized mineral supplements market and study goals. Moreover, it contacts the division study gave in the report based on the sort of item and applications.

Market Outline: This area stresses the key investigations, market development rate, serious scene, market drivers, patterns, and issues notwithstanding the naturally visible pointers.

Market Production by Region: The report conveys information identified with import and fare, income, creation, and key players of every single local market contemplated are canvassed right now.

Also Read:  Hearing Loss Disease Treatment Market Size, Growth, Report 2033

Market Players

The report includes the profiles of key mineral supplements market companies along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information, key development in past five years.

Recent Developments

  • In September 2023, Sanofi declared the successful conclusion of its acquisition of Qunol, the top-ranking health and wellness brand in the United States market. With a focus on the active “healthy aging” market, this transaction enhances Sanofi’s Consumer Healthcare’s (CHC) Vitamin, Mineral, & Supplements (VMS) category, which is among the largest and most rapidly expanding consumer health segments in the United States.

Mineral Supplements Market Companies

  • Glanbia, plc.
  • Abbott
  • Nestle
  • Biovea
  • Herbalife International of America, Inc.
  • Sanofi
  • Amway
  • Bayer AG
  • Omega Protein Corporation
  • Bio Botanica, Inc.
  • Pharmavite LLC
  • DSM
  • Nu Skin

Segments Covered in the Report

By Product

  • Calcium
  • Magnesium
  • Iron
  • Potassium
  • Zinc
  • Chromium
  • Selenium
  • Others

By Formulation

  • Capsule
  • Tablet
  • Powder
  • Liquid/Gel
  • Others

By Application

  • General Health
  • Bone & Joint Health
  • Gastrointestinal Health
  • Immunity
  • Others

By End-Use

  • Adults
  • Geriatric
  • Pregnant Women
  • Children
  • Infants

By Sales Channel

  • Pharmacies & Drug Stores
  • Supermarkets & Hypermarkets
  • Online Channels

Regional Segmentation

  • North America (U.S., Canada, Mexico)
  • Europe (Germany, France, U.K., Italy, Spain, Rest of Europe)
  • Asia-Pacific (China, Japan, India, Southeast Asia and Rest of APAC)
  • Latin America (Brazil and Rest of Latin America)
  • Middle East and Africa (GCC, North Africa, South Africa, Rest of MEA)

Research Methodology

Secondary Research

It involves company databases such as Hoover’s: This assists us to recognize financial information, the structure of the market participants and industry’s competitive landscape.

The secondary research sources referred in the process are as follows:

  • Governmental bodies, and organizations creating economic policies
  • National and international social welfare institutions
  • Company websites, financial reports and SEC filings, broker and investor reports
  • Related patent and regulatory databases
  • Statistical databases and market reports
  • Corporate Presentations, news, press release, and specification sheet of Manufacturers

Primary Research

Primary research includes face-to-face interviews, online surveys, and telephonic interviews.

  • Means of primary research: Email interactions, telephonic discussions and Questionnaire-based research etc.
  • In order to validate our research findings and analysis, we conduct primary interviews of key industry participants. Insights from primary respondents help in validating the secondary research findings. It also develops Research Team’s expertise and market understanding.

TABLE OF CONTENT

Chapter 1. Introduction

1.1. Research Objective

1.2. Scope of the Study

1.3. Definition

Chapter 2. Research Methodology (Premium Insights)

2.1. Research Approach

2.2. Data Sources

2.3. Assumptions & Limitations

Chapter 3. Executive Summary

3.1. Market Snapshot

Chapter 4. Market Variables and Scope 

4.1. Introduction

4.2. Market Classification and Scope

4.3. Industry Value Chain Analysis

4.3.1. Raw Material Procurement Analysis

4.3.2. Sales and Distribution Channel Analysis

4.3.3. Downstream Buyer Analysis

Chapter 5. COVID 19 Impact on Mineral Supplements Market 

5.1. COVID-19 Landscape: Mineral Supplements Industry Impact

5.2. COVID 19 – Impact Assessment for the Industry

5.3. COVID 19 Impact: Global Major Government Policy

5.4. Market Trends and Opportunities in the COVID-19 Landscape

Chapter 6. Market Dynamics Analysis and Trends

6.1. Market Dynamics

6.1.1. Market Drivers

6.1.2. Market Restraints

6.1.3. Market Opportunities

6.2. Porter’s Five Forces Analysis

6.2.1. Bargaining power of suppliers

6.2.2. Bargaining power of buyers

6.2.3. Threat of substitute

6.2.4. Threat of new entrants

6.2.5. Degree of competition

Chapter 7. Competitive Landscape

7.1.1. Company Market Share/Positioning Analysis

7.1.2. Key Strategies Adopted by Players

7.1.3. Vendor Landscape

7.1.3.1. List of Suppliers

7.1.3.2. List of Buyers

Chapter 8. Global Mineral Supplements Market, By Product

8.1. Mineral Supplements Market Revenue and Volume, by Product, 2024-2033

8.1.1. Calcium

8.1.1.1. Market Revenue and Volume Forecast (2021-2033)

8.1.2. Magnesium

8.1.2.1. Market Revenue and Volume Forecast (2021-2033)

8.1.3. Iron

8.1.3.1. Market Revenue and Volume Forecast (2021-2033)

8.1.4. Potassium

8.1.4.1. Market Revenue and Volume Forecast (2021-2033)

8.1.5. Zinc

8.1.5.1. Market Revenue and Volume Forecast (2021-2033)

8.1.6. Chromium

8.1.6.1. Market Revenue and Volume Forecast (2021-2033)

8.1.7. Selenium

8.1.7.1. Market Revenue and Volume Forecast (2021-2033)

8.1.8. Others

8.1.8.1. Market Revenue and Volume Forecast (2021-2033)

Chapter 9. Global Mineral Supplements Market, By Formulation

9.1. Mineral Supplements Market Revenue and Volume, by Formulation, 2024-2033

9.1.1. Capsule

9.1.1.1. Market Revenue and Volume Forecast (2021-2033)

9.1.2. Dessert

9.1.2.1. Market Revenue and Volume Forecast (2021-2033)

9.1.3. Powder

9.1.3.1. Market Revenue and Volume Forecast (2021-2033)

9.1.4. Liquid/Gel

9.1.4.1. Market Revenue and Volume Forecast (2021-2033)

9.1.5. Others

9.1.5.1. Market Revenue and Volume Forecast (2021-2033)

Chapter 10. Global Mineral Supplements Market, By Application 

10.1. Mineral Supplements Market Revenue and Volume, by Application, 2024-2033

10.1.1. General Health

10.1.1.1. Market Revenue and Volume Forecast (2021-2033)

10.1.2. Bone & Joint Health

10.1.2.1. Market Revenue and Volume Forecast (2021-2033)

10.1.3. Gastrointestinal Health

10.1.3.1. Market Revenue and Volume Forecast (2021-2033)

10.1.4. Immunity

10.1.4.1. Market Revenue and Volume Forecast (2021-2033)

10.1.5. Others

10.1.5.1. Market Revenue and Volume Forecast (2021-2033)

Chapter 11. Global Mineral Supplements Market, By End-Use

11.1. Mineral Supplements Market Revenue and Volume, by End-Use, 2024-2033

11.1.1. Adults

11.1.1.1. Market Revenue and Volume Forecast (2021-2033)

11.1.2. Geriatric

11.1.2.1. Market Revenue and Volume Forecast (2021-2033)

11.1.3. Pregnant Women

11.1.3.1. Market Revenue and Volume Forecast (2021-2033)

11.1.4. Children

11.1.4.1. Market Revenue and Volume Forecast (2021-2033)

11.1.5. Infants

11.1.5.1. Market Revenue and Volume Forecast (2021-2033)

Chapter 12. Global Mineral Supplements Market, By Sales Channel

12.1. Mineral Supplements Market Revenue and Volume, by Sales Channel, 2024-2033

12.1.1. Pharmacies & Drug Stores

12.1.1.1. Market Revenue and Volume Forecast (2021-2033)

12.1.2. Supermarkets & Hypermarkets

12.1.2.1. Market Revenue and Volume Forecast (2021-2033)

12.1.3. Online Channels

12.1.3.1. Market Revenue and Volume Forecast (2021-2033)

Chapter 13. Global Mineral Supplements Market, Regional Estimates and Trend Forecast

13.1. North America

13.1.1. Market Revenue and Volume Forecast, by Product (2021-2033)

13.1.2. Market Revenue and Volume Forecast, by Formulation (2021-2033)

13.1.3. Market Revenue and Volume Forecast, by Application (2021-2033)

13.1.4. Market Revenue and Volume Forecast, by End-Use (2021-2033)

13.1.5. Market Revenue and Volume Forecast, by Sales Channel (2021-2033)

13.1.6. U.S.

13.1.6.1. Market Revenue and Volume Forecast, by Product (2021-2033)

13.1.6.2. Market Revenue and Volume Forecast, by Formulation (2021-2033)

13.1.6.3. Market Revenue and Volume Forecast, by Application (2021-2033)

13.1.6.4. Market Revenue and Volume Forecast, by End-Use (2021-2033)

13.1.6.5. Market Revenue and Volume Forecast, by Sales Channel (2021-2033)

13.1.7. Rest of North America

13.1.7.1. Market Revenue and Volume Forecast, by Product (2021-2033)

13.1.7.2. Market Revenue and Volume Forecast, by Formulation (2021-2033)

13.1.7.3. Market Revenue and Volume Forecast, by Application (2021-2033)

13.1.7.4. Market Revenue and Volume Forecast, by End-Use (2021-2033)

13.1.7.5. Market Revenue and Volume Forecast, by Sales Channel (2021-2033)

13.2. Europe

13.2.1. Market Revenue and Volume Forecast, by Product (2021-2033)

13.2.2. Market Revenue and Volume Forecast, by Formulation (2021-2033)

13.2.3. Market Revenue and Volume Forecast, by Application (2021-2033)

13.2.4. Market Revenue and Volume Forecast, by End-Use (2021-2033)

13.2.5. Market Revenue and Volume Forecast, by Sales Channel (2021-2033)

13.2.6. UK

13.2.6.1. Market Revenue and Volume Forecast, by Product (2021-2033)

13.2.6.2. Market Revenue and Volume Forecast, by Formulation (2021-2033)

13.2.6.3. Market Revenue and Volume Forecast, by Application (2021-2033)

13.2.7. Market Revenue and Volume Forecast, by End-Use (2021-2033)

13.2.8. Market Revenue and Volume Forecast, by Sales Channel (2021-2033)

13.2.9. Germany

13.2.9.1. Market Revenue and Volume Forecast, by Product (2021-2033)

13.2.9.2. Market Revenue and Volume Forecast, by Formulation (2021-2033)

13.2.9.3. Market Revenue and Volume Forecast, by Application (2021-2033)

13.2.10. Market Revenue and Volume Forecast, by End-Use (2021-2033)

13.2.11. Market Revenue and Volume Forecast, by Sales Channel (2021-2033)

13.2.12. France

13.2.12.1. Market Revenue and Volume Forecast, by Product (2021-2033)

13.2.12.2. Market Revenue and Volume Forecast, by Formulation (2021-2033)

13.2.12.3. Market Revenue and Volume Forecast, by Application (2021-2033)

13.2.12.4. Market Revenue and Volume Forecast, by End-Use (2021-2033)

13.2.13. Market Revenue and Volume Forecast, by Sales Channel (2021-2033)

13.2.14. Rest of Europe

13.2.14.1. Market Revenue and Volume Forecast, by Product (2021-2033)

13.2.14.2. Market Revenue and Volume Forecast, by Formulation (2021-2033)

13.2.14.3. Market Revenue and Volume Forecast, by Application (2021-2033)

13.2.14.4. Market Revenue and Volume Forecast, by End-Use (2021-2033)

13.2.15. Market Revenue and Volume Forecast, by Sales Channel (2021-2033)

13.3. APAC

13.3.1. Market Revenue and Volume Forecast, by Product (2021-2033)

13.3.2. Market Revenue and Volume Forecast, by Formulation (2021-2033)

13.3.3. Market Revenue and Volume Forecast, by Application (2021-2033)

13.3.4. Market Revenue and Volume Forecast, by End-Use (2021-2033)

13.3.5. Market Revenue and Volume Forecast, by Sales Channel (2021-2033)

13.3.6. India

13.3.6.1. Market Revenue and Volume Forecast, by Product (2021-2033)

13.3.6.2. Market Revenue and Volume Forecast, by Formulation (2021-2033)

13.3.6.3. Market Revenue and Volume Forecast, by Application (2021-2033)

13.3.6.4. Market Revenue and Volume Forecast, by End-Use (2021-2033)

13.3.7. Market Revenue and Volume Forecast, by Sales Channel (2021-2033)

13.3.8. China

13.3.8.1. Market Revenue and Volume Forecast, by Product (2021-2033)

13.3.8.2. Market Revenue and Volume Forecast, by Formulation (2021-2033)

13.3.8.3. Market Revenue and Volume Forecast, by Application (2021-2033)

13.3.8.4. Market Revenue and Volume Forecast, by End-Use (2021-2033)

13.3.9. Market Revenue and Volume Forecast, by Sales Channel (2021-2033)

13.3.10. Japan

13.3.10.1. Market Revenue and Volume Forecast, by Product (2021-2033)

13.3.10.2. Market Revenue and Volume Forecast, by Formulation (2021-2033)

13.3.10.3. Market Revenue and Volume Forecast, by Application (2021-2033)

13.3.10.4. Market Revenue and Volume Forecast, by End-Use (2021-2033)

13.3.10.5. Market Revenue and Volume Forecast, by Sales Channel (2021-2033)

13.3.11. Rest of APAC

13.3.11.1. Market Revenue and Volume Forecast, by Product (2021-2033)

13.3.11.2. Market Revenue and Volume Forecast, by Formulation (2021-2033)

13.3.11.3. Market Revenue and Volume Forecast, by Application (2021-2033)

13.3.11.4. Market Revenue and Volume Forecast, by End-Use (2021-2033)

13.3.11.5. Market Revenue and Volume Forecast, by Sales Channel (2021-2033)

13.4. MEA

13.4.1. Market Revenue and Volume Forecast, by Product (2021-2033)

13.4.2. Market Revenue and Volume Forecast, by Formulation (2021-2033)

13.4.3. Market Revenue and Volume Forecast, by Application (2021-2033)

13.4.4. Market Revenue and Volume Forecast, by End-Use (2021-2033)

13.4.5. Market Revenue and Volume Forecast, by Sales Channel (2021-2033)

13.4.6. GCC

13.4.6.1. Market Revenue and Volume Forecast, by Product (2021-2033)

13.4.6.2. Market Revenue and Volume Forecast, by Formulation (2021-2033)

13.4.6.3. Market Revenue and Volume Forecast, by Application (2021-2033)

13.4.6.4. Market Revenue and Volume Forecast, by End-Use (2021-2033)

13.4.7. Market Revenue and Volume Forecast, by Sales Channel (2021-2033)

13.4.8. North Africa

13.4.8.1. Market Revenue and Volume Forecast, by Product (2021-2033)

13.4.8.2. Market Revenue and Volume Forecast, by Formulation (2021-2033)

13.4.8.3. Market Revenue and Volume Forecast, by Application (2021-2033)

13.4.8.4. Market Revenue and Volume Forecast, by End-Use (2021-2033)

13.4.9. Market Revenue and Volume Forecast, by Sales Channel (2021-2033)

13.4.10. South Africa

13.4.10.1. Market Revenue and Volume Forecast, by Product (2021-2033)

13.4.10.2. Market Revenue and Volume Forecast, by Formulation (2021-2033)

13.4.10.3. Market Revenue and Volume Forecast, by Application (2021-2033)

13.4.10.4. Market Revenue and Volume Forecast, by End-Use (2021-2033)

13.4.10.5. Market Revenue and Volume Forecast, by Sales Channel (2021-2033)

13.4.11. Rest of MEA

13.4.11.1. Market Revenue and Volume Forecast, by Product (2021-2033)

13.4.11.2. Market Revenue and Volume Forecast, by Formulation (2021-2033)

13.4.11.3. Market Revenue and Volume Forecast, by Application (2021-2033)

13.4.11.4. Market Revenue and Volume Forecast, by End-Use (2021-2033)

13.4.11.5. Market Revenue and Volume Forecast, by Sales Channel (2021-2033)

13.5. Latin America

13.5.1. Market Revenue and Volume Forecast, by Product (2021-2033)

13.5.2. Market Revenue and Volume Forecast, by Formulation (2021-2033)

13.5.3. Market Revenue and Volume Forecast, by Application (2021-2033)

13.5.4. Market Revenue and Volume Forecast, by End-Use (2021-2033)

13.5.5. Market Revenue and Volume Forecast, by Sales Channel (2021-2033)

13.5.6. Brazil

13.5.6.1. Market Revenue and Volume Forecast, by Product (2021-2033)

13.5.6.2. Market Revenue and Volume Forecast, by Formulation (2021-2033)

13.5.6.3. Market Revenue and Volume Forecast, by Application (2021-2033)

13.5.6.4. Market Revenue and Volume Forecast, by End-Use (2021-2033)

13.5.7. Market Revenue and Volume Forecast, by Sales Channel (2021-2033)

13.5.8. Rest of LATAM

13.5.8.1. Market Revenue and Volume Forecast, by Product (2021-2033)

13.5.8.2. Market Revenue and Volume Forecast, by Formulation (2021-2033)

13.5.8.3. Market Revenue and Volume Forecast, by Application (2021-2033)

13.5.8.4. Market Revenue and Volume Forecast, by End-Use (2021-2033)

13.5.8.5. Market Revenue and Volume Forecast, by Sales Channel (2021-2033)

Chapter 14. Company Profiles

14.1. Glanbia, plc.

14.1.1. Company Overview

14.1.2. Product Offerings

14.1.3. Financial Performance

14.1.4. Recent Initiatives

14.2. Abbott

14.2.1. Company Overview

14.2.2. Product Offerings

14.2.3. Financial Performance

14.2.4. Recent Initiatives

14.3. Nestle

14.3.1. Company Overview

14.3.2. Product Offerings

14.3.3. Financial Performance

14.3.4. Recent Initiatives

14.4. Biovea

14.4.1. Company Overview

14.4.2. Product Offerings

14.4.3. Financial Performance

14.4.4. Recent Initiatives

14.5. Herbalife International of America, Inc.

14.5.1. Company Overview

14.5.2. Product Offerings

14.5.3. Financial Performance

14.5.4. Recent Initiatives

14.6. Sanofi

14.6.1. Company Overview

14.6.2. Product Offerings

14.6.3. Financial Performance

14.6.4. Recent Initiatives

14.7. Amway

14.7.1. Company Overview

14.7.2. Product Offerings

14.7.3. Financial Performance

14.7.4. Recent Initiatives

14.8. Bayer AG

14.8.1. Company Overview

14.8.2. Product Offerings

14.8.3. Financial Performance

14.8.4. Recent Initiatives

14.9. Omega Protein Corporation

14.9.1. Company Overview

14.9.2. Product Offerings

14.9.3. Financial Performance

14.9.4. Recent Initiatives

14.10. Bio Botanica, Inc.

14.10.1. Company Overview

14.10.2. Product Offerings

14.10.3. Financial Performance

14.10.4. Recent Initiatives

Chapter 15. Research Methodology

15.1. Primary Research

15.2. Secondary Research

15.3. Assumptions

Chapter 16. Appendix

16.1. About Us

16.2. Glossary of Terms

Thanks for reading you can also get individual chapter-wise sections or region-wise report versions such as North America, Europe, or the Asia Pacific.

Contact Us:

Mr. Alex

Sales Manager

Call: +1 9197 992 333

Emailsales@precedenceresearch.com

Web: https://www.precedenceresearch.com

Blog: https://www.pharma-geek.com


Prathamesh

Leave a Reply

Your email address will not be published. Required fields are marked *